PDF (872K)
摘要
目的 探讨葛根素通过miR-485-3p/Notch2信号通路对动脉粥样硬化(AS)大鼠炎症反应的影响。方法 将SD大鼠分为对照组、AS组、葛根素组、葛根素+antagomir NC组、葛根素+miR-485-3p antagomir组,每组12只。检测血脂水平、胸主动脉病理变化、炎症因子水平以及CD206、诱导型一氧化氮合酶(iNOS)、miR-485-3p和Notch2蛋白表达水平,验证miR-485-3p与Notch2的关系。结果 与对照组比较,AS组大鼠胸主动脉有AS斑块形成,动脉壁变厚,血清中甘油三酯、低密度脂蛋白胆固醇、总胆固醇水平,胸主动脉中肿瘤坏死因子α水平、白细胞介素-6水平、血管细胞黏附分子-1水平、iNOS相对荧光强度、Notch2蛋白表达水平升高,胸主动脉中CD206相对荧光强度、miR-485-3p表达水平降低(P < 0.05);与AS组比较,葛根素组上述指标变化呈相反趋势(P < 0.05);miR-485-3p antagomir减弱了葛根素对AS大鼠炎症反应的抑制作用。miR-485-3p与Notch2存在靶向关系。结论 葛根素可能通过调控miR-485-3p/Notch2信号通路减轻AS大鼠炎症反应。
Abstract
Objective To investigate the effects of puerarin on inflammatory response in atherosclerotic (AS) rats via the miR-485-3p/Notch2 signaling pathway. Methods SD rats were divided into control, AS, puerarin, puerarin+antagomir NC, and puerarin+miR-485-3p antagomir groups, with 12 rats in each group. Blood lipid levels, thoracic aorta pathology, inflammatory factor levels, and expression levels of CD206, inducible nitric oxide synthase (iNOS), miR-485-3p, and Notch2 protein were detected. The relationship between miR-485-3p and Notch2 was verified. Results Compared with the control group, the AS group showed AS plaque formation in the thoracic aorta, thickened arterial wall, increased serum levels of triglyceride, low-density lipoprotein cholesterol, and total cholesterol, elevated levels of tumor necrosis factor α, interleukin-6, and vascular cell adhesion molecule-1 in the thoracic aorta, increased relative fluorescence intensity of iNOS, and upregulated Notch2 protein expression as well as decreased relative fluorescence intensity of CD206 and downregulated miR-485-3p expression in the thoracic aorta (P < 0.05). Compared with the AS group, the above-mentioned indicators showed the opposite trend in the puerarin group (P < 0.05). miR-485-3p antagomir attenuated the inhibitory effect of puerarin on the inflammatory response of AS rats. A targeting relationship was confirmed between miR-485-3p and Notch2. Conclusion Puerarin may attenuate the inflammatory response in AS rats by regulating the miR-485-3p/Notch2 signaling pathway.
关键词
Key words
[Author(id=1329092169361883227, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329092169416409185, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, authorId=1329092169361883227, language=EN, stringName=Lifen CHEN, firstName=Lifen, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Peripheral Vascular,Henan Province Hospital of TCM (The Second Affiliated Hospital of Henan University of Chinese Medicine), Zhengzhou 450000,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329092169462546532, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, authorId=1329092169361883227, language=CN, stringName=陈利芬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河南省中医院(河南中医药大学第二附属医院) 周围血管科, 郑州 450000, bio={"content":"陈利芬(1990-),女,主治医师,硕士.
"}, bioImg=null, bioContent=陈利芬(1990-),女,主治医师,硕士.
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329092169290580051, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, xref=null, ext=[AuthorCompanyExt(id=1329092169303162965, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, companyId=1329092169290580051, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Peripheral Vascular,Henan Province Hospital of TCM (The Second Affiliated Hospital of Henan University of Chinese Medicine), Zhengzhou 450000,China), AuthorCompanyExt(id=1329092169315745878, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, companyId=1329092169290580051, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河南省中医院(河南中医药大学第二附属医院) 周围血管科, 郑州 450000)])]), Author(id=1329092169508683880, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329092169567404142, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, authorId=1329092169508683880, language=EN, stringName=Hui LIU, firstName=Hui, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Peripheral Vascular,Henan Province Hospital of TCM (The Second Affiliated Hospital of Henan University of Chinese Medicine), Zhengzhou 450000,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329092169609347185, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, authorId=1329092169508683880, language=CN, stringName=刘辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河南省中医院(河南中医药大学第二附属医院) 周围血管科, 郑州 450000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329092169290580051, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, xref=null, ext=[AuthorCompanyExt(id=1329092169303162965, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, companyId=1329092169290580051, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Peripheral Vascular,Henan Province Hospital of TCM (The Second Affiliated Hospital of Henan University of Chinese Medicine), Zhengzhou 450000,China), AuthorCompanyExt(id=1329092169315745878, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, companyId=1329092169290580051, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河南省中医院(河南中医药大学第二附属医院) 周围血管科, 郑州 450000)])]), Author(id=1329092169655484533, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=13838181069@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329092169714204794, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, authorId=1329092169655484533, language=EN, stringName=Jianpeng LI, firstName=Jianpeng, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Peripheral Vascular,Henan Province Hospital of TCM (The Second Affiliated Hospital of Henan University of Chinese Medicine), Zhengzhou 450000,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329092169756147837, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, authorId=1329092169655484533, language=CN, stringName=李建鹏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河南省中医院(河南中医药大学第二附属医院) 周围血管科, 郑州 450000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329092169290580051, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, xref=null, ext=[AuthorCompanyExt(id=1329092169303162965, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, companyId=1329092169290580051, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Peripheral Vascular,Henan Province Hospital of TCM (The Second Affiliated Hospital of Henan University of Chinese Medicine), Zhengzhou 450000,China), AuthorCompanyExt(id=1329092169315745878, tenantId=1045748351789510663, journalId=1155139928303341696, articleId=1329032655937348300, companyId=1329092169290580051, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河南省中医院(河南中医药大学第二附属医院) 周围血管科, 郑州 450000)])])]
陈利芬,刘辉,李建鹏.
葛根素通过miR-485-3p/Notch2信号通路减轻动脉粥样硬化大鼠炎症反应[J].
中国医科大学学报, 2026, 55(7): 633-638 DOI:10.12007/j.issn.0258‐4646.2026.07.011
| [1] |
VIRANI SS,ALONSO A,BENJAMIN EJ,et al. Heart disease and stroke statistics-2020 update:a report from the American Heart Association [J]. Circulation,2020,141 (9):e139-e596. DOI:10.1161/CIR.0000000000000757.
|
| [2] |
MENG D,DENG X,WU Y,et al. Corilagin ameliorates macrophages inflammation in atherosclerosis through TLR4-NFκB/MAPK pathway [J]. Heliyon,2023,9 (6):e16960. DOI:10.1016/j.heliyon.2023.e16960.
|
| [3] |
HOU C,JIANG X,SHENG W,et al. Xinmaikang (XMK) tablets alleviate atherosclerosis by regulating the SREBP2-mediated NLRP3/ASC/Caspase-1 signaling pathway [J]. J Ethnopharmacol,2024,319:117240. DOI:10.1016/j.jep.2023.117240.
|
| [4] |
MENG T,LI X,LI C,et al. Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways [J].Front Pharmacol,2022,13:997598. DOI:10.3389/fphar.2022.997598.
|
| [5] |
ZHOU YX,ZHANG H,PENG C. Effects of puerarin on the prevention and treatment of cardiovascular diseases [J]. Front Pharmacol,2021,12:771793. DOI:10.3389/fphar.2021.771793.
|
| [6] |
胡彦武,杨温欣,包小雪,等. 葛根素改善动脉粥样硬化大鼠血脂异常及炎症反应的作用机制 [J]. 医药导报,2021,40 (2):175-179. DOI:10.3870/j.issn.1004-0781.2021.02.005.
|
| [7] |
YANG L,LIN Y,WANG C,et al. circSnd1 promotes atherosclerosis progression through the miR-485-3p/Olr1 signaling pathway [J]. Heliyon,2023,9 (6):e17366. DOI:10.1016/j.heliyon.2023.e17366.
|
| [8] |
DAVIS-KNOWLTON J,TURNER JE,TURNER A,et al. Characterization of smooth muscle cells from human atherosclerotic lesions and their responses to Notch signaling [J]. Lab Investig,2019,99 (3):290-304. DOI:10.1038/s41374-018-0072-1.
|
| [9] |
LI J,LI Y,YUAN X,et al. The effective constituent puerarin,from Pueraria lobata,inhibits the proliferation and inflammation of vascular smooth muscle in atherosclerosis through the miR-29b-3p/IGF1 pathway [J]. Pharm Biol,2023,61 (1):1-11. DOI:10.1080/13880209.2022.2099430.
|
| [10] |
王建民,孟蓓,王胜利,等. 通窍活血汤对动脉粥样硬化大鼠SIRT1/PGC1α通路及斑块稳定性的影响 [J]. 中国老年学杂志,2023,43 (12):3009-3013. DOI:10.3969/j.issn.1005-9202.2023.12.050.
|
| [11] |
田蜜,武国利. miR-499-5p上调对动脉粥样硬化大鼠心肌细胞凋亡的影响及作用机制 [J]. 中国临床研究,2021,34 (1):27-31. DOI:10.13429/j.cnki.cjcr.2021.01.006.
|
| [12] |
ZHAO L,DING LD,XIA ZH,et al. A network-based approach to investigate the neuroprotective effects and mechanisms of action of Huangqi-Chuanxiong and Sanleng-Ezhu herb pairs in the treatment of cerebral ischemic stroke [J]. Front Pharmacol,2022,13:844186. DOI:10.3389/fphar.2022.844186.
|
| [13] |
陈婧,薛晓琳,叶超,等. 益气化痰活血法对血脂异常痰浊阻遏证小鼠动脉粥样硬化相关炎性因子IL-6、TNF-α表达的影响 [J]. 现代中西医结合杂志,2022,31 (4):445-448. DOI:10.3969/j.issn.1008-8849.2022.04.002.
|
| [14] |
WENG J,CHEN M,SHI B,et al. Konjac glucomannan defends against high-fat diet-induced atherosclerosis in rabbits by promoting the PI3K/Akt pathway [J]. Heliyon,2023,9 (2):e13682. DOI:10.1016/j.heliyon.2023.e13682.
|
| [15] |
WANG D,TAN Z,YANG J,et al. Perfluorooctane sulfonate promotes atherosclerosis by modulating M1 polarization of macrophages through the NF-κB pathway [J]. Ecotoxicol Environ Saf,2023,249:114384. DOI:10.1016/j.ecoenv.2022.114384.
|
| [16] |
ZHOU J,ZHANG N,ALDHAHRANI A,et al. Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation,oxidative stress,and inflammation [J]. Front Immunol,2022,13:956688. DOI:10.3389/fimmu.2022.956688.
|
| [17] |
章平衡,李春燕,刘永源,等. 葛根素通过抑制ox-LDL诱导巨噬细胞焦亡通路活化稳定AS易损斑块 [J]. 中国免疫学杂志,2021,37 (18):2212-2216. DOI:10.3969/j.issn.1000-484X.2021.18.007.
|
| [18] |
ZHOU F,CAO C,CHAI H,et al. Circ-HACE1 aggravates cigarette smoke extract-induced injury in human bronchial epithelial cells via regulating toll-like receptor 4 by sponging miR-485-3p [J]. Int J Chronic Obstr Pulm Dis,2021,16:1535-1547. DOI:10.2147/COPD.S304859.
|
| [19] |
曹春风,邵高海,张铭华,等. 基于Notch/STAT3信号通路探讨bFGF对大鼠脊髓损伤的治疗机制 [J]. 中国修复重建外科杂志,2024,38 (4):480-486. DOI:10.7507/1002-1892.202312066.
|
基金资助
河南省中医药拔尖人才培养项目专项课题(2022ZYBJ12)